(Q36392717)

13 August 2017

Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1. (English)

1 reference

13 August 2017

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Hisashi Narimatsu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Atsushi Matsuda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Michiyo Higashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Tomomi Nakagawa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Seiya Yokoyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Suguru Yonezawa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

5 June 2017

1 reference

13 August 2017

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

1103-1113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28581490%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2017.53

13 June 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Glycomics hits the big time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The Art of Destruction: Optimizing Collision Energies in Quadrupole-Time of Flight (Q-TOF) Instruments for Glycopeptide-Based Glycoproteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Mucins in cancer: protection and control of the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Mucins in cancer: function, prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The cancer glycocalyx mechanically primes integrin-mediated growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The sweet and sour of cancer: glycans as novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Glycoprotein structure determination by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Glycosylation and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Linkage-Specific in Situ Sialic Acid Derivatization for N-Glycan Mass Spectrometry Imaging of Formalin-Fixed Paraffin-Embedded Tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Focused differential glycan analysis with the platform antibody-assisted lectin profiling for glycan-related biomarker verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Development of an all-in-one technology for glycan profiling targeting formalin-embedded tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Glycome diagnosis of human induced pluripotent stem cells using lectin microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Clinical diagnosis and staging of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Use of a library of mutated Maackia amurensis hemagglutinin for profiling the cell lineage and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

Large-Scale Identification of N-Glycan Glycoproteins Carrying Lewis x and Site-Specific N-Glycan Alterations in Fut9 Knockout Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Multilectin-assisted fractionation for improved single-dot tissue glycome profiling in clinical glycoproteomics

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Strong affinity of Maackia amurensis hemagglutinin (MAH) for sialic acid-containing Ser/Thr-linked carbohydrate chains of N-terminal octapeptides from human glycophorin A

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Laser-capture microdissection

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2017.53

7 January 2021

Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28581490

12 December 2020

inferred from PubMed ID database lookup

Studies on Hemagglutinins from Maackia amurensis Seeds

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28581490

12 December 2020